Sedation



Sedation


Angela Kendrick

Dawn M. Larson



▪ INTRODUCTION

Intravenous (IV) anesthetics may be used for induction of general anesthesia, maintenance of general anesthesia, and sedation. Sedation typically involves an agent called a “sedative-hypnotic” and refers to a state of calm and relaxation, whereas hypnosis refers to sleep. A sedative is often combined with an analgesic, which is used to treat pain. The combination of the two agents can be very effective; however, it may also potentiate each medication more than if they were given independently. Sedation involves a continuum from minimal sedation leading to moderate and deep sedation and eventually to general anesthesia. The definition of these states of consciousness has been published by the American Society of Anesthesiologists (ASA). In addition, the ASA has published practice guidelines for those who may administer sedation and standard monitoring required during a sedation case. The term monitored anesthesia care (MAC) does not refer to the depth of anesthesia but rather a sedation or service that is provided by an anesthesiologist. The term is falling out of favor and is being replaced by the term depth of sedation, regardless of who provides the service. Sedation is useful in a variety of settings: the intensive care unit (ICU) sedation for mechanical ventilation, sedation for procedures or imaging, and as an adjunct to regional anesthesia in the operating room (OR).


▪ DEFINITION OF THE DEPTH AND LEVELS OF SEDATION/ANALGESIA

Minimal Sedation (Anxiolysis): Cognitive function may be impaired, but there is a normal response to verbal stimuli with unaffected airway, ventilation, or cardiovascular function.

Moderate Sedation/Anesthesia (aka Conscious Sedation): Purposeful response to verbal or tactile stimuli with airway, ventilation, and cardiovascular functions that are adequate and should require no intervention.

Deep Sedation/Analgesia: Purposeful response only following repeated or painful stimulation where the airway and ventilation often need support and the cardiovascular function is usually maintained. Providers who perform deep sedation should be qualified to respond to a patient who enters a state of general anesthesia.

General Anesthesia: Unresponsive even to painful stimuli where the airway and ventilation are generally inadequate without intervention and the cardiac function may need intervention (Table 17.1).


▪ PREEVALUATION FOR SEDATION CASES

A task force of the ASA on sedation guidelines recommends that the clinician performing the sedation performs an assessment of the patient prior to administration of sedation. This should include the patient’s medical history, vital signs, allergies, current medications, response to previous sedation, and history of substance abuse. Additionally, a focused physical examination including heart and lung auscultation and airway evaluation should be included.

An explanation of the risks, benefits, and alternatives of the level of sedation required should be provided to patients or their legal guardian prior to the procedure. Patients undergoing sedation should be advised not to eat solids or drink liquids according to the ASA guidelines for perioperative fasting. In emergency situations, the risks and benefits of sedation on nonfasted individuals should be considered and discussed with the patient or guardian regarding the potential for pulmonary aspiration of gastric contents (Table 17.2).









TABLE 17.1 AMERICAN SOCIETY OF ANESTHESIOLOGY DEPTH OF ANESTHESIA DEFINITIONS


































MINIMAL SEDATION (ANXIOLYSIS)


MODERATE SEDATION/ANALGESIA (CONSCIOUS SEDATION)


DEEP SEDATION/ANALGESIA


GENERAL ANESTHESIA


Responsiveness


Normal response to verbal stimulation


Purposeful response to verbal or tactile stimulation


Purposeful response after repeated or painful stimulation


Unarousable, even with painful stimulus


Airway


Unaffected


No intervention required


Intervention may be required


Intervention often required


Spontaneous ventilation


Unaffected


Adequate


May be inadequate


Frequently inadequate


Cardiovascular function


Unaffected


Usually maintained


Usually maintained


May be impaired


Monitoring is recommended by the ASA according to the level of sedation. Data should be recorded prior to the start of sedation, during the procedure, and after completion (Table 17.3).

The personnel performing the sedation should not be the person performing the procedure and should be present to administer medications and monitor the patient during the procedure. This person may help with minor tasks related to the procedure when the patient is stable; however, he or she may not perform these tasks during a deep sedation. Additionally, he or she should be knowledgeable of the pharmacology of both sedating and analgesic medications as well as the reversal agents for those medications. There should be a basic life support (BLS) certified health care provider in the room, with advanced cardiac life support (ACLS) personnel available within 5 minutes. The exception is the administration of deep sedation, which requires the presence of an ACLS certified provider in the room.








TABLE 17.2 AMERICAN SOCIETY OF ANESTHESIOLOGY FASTING GUIDELINES























INTAKE


MINIMUM FASTING PERIOD


Clear liquids


2 h


Breast milk


4 h


Nonhuman milk


6 h


Light meala


6 h


Heavy meal


8 h


a Light meal typically consists of clears and non-fat-based snack.



▪ SEDATION SCALES

Many sedation scales exist to help categorize the level of arousal during a procedure or within the ICU. They attempt to standardize the level of consciousness to facilitate communication between providers. Two of the more common scales are the Ramsay Scale, which was introduced over 30 years ago, and the Riker Sedation-Agitation Scale (SAS) (Tables 17.4 and 17.5).


▪ SUPPORT EQUIPMENT

Because sedation is a continuum and medications are used that can cause respiratory depression and hemodynamic compromise, rescue equipment should be readily available (Table 17.6).


▪ SEDATION AGENTS


Propofol

Propofol is in the class of akylphenols and produces a state of anesthesia without analgesic (pain-relieving) properties. The mechanism of action is primarily by activation of γ-aminobutyric acid (GABA) receptors. It is lipid soluble and is prepared in an emulsion that consists of soybean oil, purified egg phosphatide, glycerol, and an inhibitor of antibacterial growth. It has a white milky appearance, is stable at room temperature, and once opened should be discarded after 6 hours to avoid bacterial contamination. It is also a potent antiemetic, even when used at dosing levels commonly used in sedation
dosing. Propofol may cause respiratory depression at therapeutic doses and a dose-dependent decrease in arterial blood pressure. Sedation dosing at 25-75 µg/kg/min is typically sufficient, although there is variability among patients. Metabolism occurs via the liver; however, other sites in the body may play a role as well. Propofol has a rapid onset and a short elimination half-life of 2-8 minutes, which is a desirable feature for sedation procedures. Because of propofol’s alternative use as an induction agent and its ability to continue into the level of general anesthesia, its use should follow guidelines for deep sedation regardless of the actual level of sedation planned.








TABLE 17.3 SEDATION MONITORING















– Pulse oximetry


– Blood pressure and heart rate at 5-minute intervals


– Electrocardiograph (EKG) for patients with cardiovascular disease and for all deep sedation procedures


– Response to verbal commands if applicable


– Adequacy of pulmonary ventilation (observation, auscultation)


– Exhaled carbon dioxide monitoring when patients are at a distance from the sedation provider and for all deep sedation procedures (via nasal canula port or an angiocath inserted into a face mask)


May 23, 2016 | Posted by in ANESTHESIA | Comments Off on Sedation

Full access? Get Clinical Tree

Get Clinical Tree app for offline access